POST-AUTHORIZATION SAFETY STUDY AGREEMENT SMLOUVA O POREGISTRAČNÍ STUDII BEZPEČNOSTIStudy Agreement • July 28th, 2017
Contract Type FiledJuly 28th, 2017This Post-authorization Safety Study Agreement (this “Agreement”) is entered into on the date of signature by the last of the contracting parties (the “Effective Date”), by and among Glaxo Group Limited, 980 Great West Road, Brentford, Middlesex, TW8 9GS UK (“Sponsor”), Quintiles Czech Republic, s.r.o., having a place of business at Praha 5, Jinonice, Radlická 714/113a, zip code 158 00 Prague, Czech Republic, Identification number: CZ247 68 651, (“Company”), Nemocnice Na Homolce (“Clinician Site), with an address at Roentgenova 2/37, 15030 Prague, Czech Republic and xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx(“Principal Investigator”). Clinician Site and Principal Investigator are hereinafter referred to collectively as “Site.”) Tato smlouva o poregistrační studii (dále jen „smlouva) je uzavřena ke dni podpisu poslední ze smluvních stran (dále jen „datum účinnosti“), a to společností Glaxo Group Limited, 980 Great West Road, Brentford, Mi